Friday 17 May |
Restaurant Group |
Bank of Georgia Group |
Centaur Media |
Cairn Energy |
Robert Walters |
Derwent London |
Hikma Pharmaceuticals |
Churchill China |
John Menzies |
Hunters Property |
Irish Continental Group |
Monday 20 May |
Keyword Studios |
Cloudcall Group |
City Pub Group |
Forterra |
Foxtons Group |
Tuesday 21 May |
BP |
Royal Dutch Shell |
Smurfit Kappa |
888 Holdings |
Accessco Technology |
Fresnillo |
JTC |
Greggs |
Contourglobal |
Provident Financial |
Metro Bank |
Hilton Food Group |
Vitec Group |
Restore |
Wednesday 22 May |
Antofagasta |
Property Franchise Group |
Sportech |
Boku |
Deltex Medical Group |
Sound Energy |
Medica Group |
Gamma Communications |
Bovis Homes Group |
French Connection Group |
Georgia Healthcare Group |
Fundsmith Emerging Equities Trust |
Thursday 23 May |
GoCompare (re: name change) |
Intertek |
Instem |
Alliance Pharma |
Avast |
SOCO International |
JKX Oil & Gas |
Ibstock |
Henry Boot |
Polypipe |
Bakkavor |
Coats Group |
Essentra |
Legal & General |
Inchcape |
IN BRIEF: Alliance Pharma drops as CEO departs, delays results again
Alliance Pharma PLC - Chippenham, Wiltshire-based distributor of consumer healthcare brands and prescription medicines - Shares close down 14% in London on Wednesday, after Alliance Pharma says Chief Executive Officer Peter Butterfield has decided to leave the company "to pursue other business interests". Following a "comprehensive" search process, it appoints Nick Sedgwick as new CEO, starting on Monday next week. Sedgwick has 30 years experience in consumer health, Alliance Pharma says, most recently as regional director for UK & Ireland Consumer Health at Reckitt Benckiser Group PLC. Butterfield will remain with Alliance Pharma until June 30 to facilitate a "thorough" handover, it says. Butterfield joined the board in 2010 and became CEO in 2018.
Read more